Please feel free to use the templates below as a basis for sharing this process with your friends, family, colleagues and patients.
The TGA’s Public Submissions Period is Open
The public consultation period ends COB on Friday 27 May 2022.
Please share these applications as widely as you can to build support for these applications before the submissions period ends.
Simply copy the content into your email software, add recipients and your name and hit send. You can edit the templates as you see fit or use them as is.
Subject 1: Please help!
Subject 2: Please help to reschedule psilocybin & MDMA
I'm writing to ask if you can do me a favour.
I've just made a submission in the TGA's public submissions process, to support a proposed rescheduling of psilocybin and MDMA.
This rescheduling will allow limited access to these substances as a part of psychotherapy, for patients with treatment resistant mental health conditions.
This is something deeply important to me, and it would mean a lot of you could make a submission as well. The more submissions we get, the stronger the signal we'll send that the TGA must take these submissions seriously.
Mind Medicine Australia - the organisation that made the applications - has prepared a how-to guide.
Please click the link below and read the guide to find out all the reasons why this rescheduling makes sense and is a kind thing to do for perople suffering with treatment resistant mental illness.
If you have any questions, please feel free to ask me or reach out to Mind Medicine Australia directly at: [email protected]
Subject 1: Please help!
Subject 2: Please help us reschedule MDMA & Psilocybin
Every so often you get a chance to be part of something historic.
To be part of something that will fundamentally shift the world we live in, for the better.
Whilst it can all seem overwhelming and frustrating at times... ultimately the world we live in, is shaped by people just like you and me.
Recently, the TGA has opened their public submissions process on the re-scheduling of Psilocybin and MDMA for medical use as part of psychotherapy for the treatment of key classes of treatment resistant mental illness.
I just made a submission in support of rescheduling these medicines and I want to ask you to do the same.
So please join me and help all Australians suffering from key classes of mental illness such as depression and PTSD both current and future by making a public submission to the TGA in support of rescheduling MDMA and Psilocybin on the limited basis envisaged in our applications.
I believe, based on both historical and emerging data, that these two substances, when used with psychotherapy in medically controlled environments can give people hope, healing and a chance at happiness.
I believe that to deny Australians access to these medicines through their psychiatrists on this restrictive basis, is a breach of their fundamental human right to the highest standard of health attainable... and that the current scheduling which claims that Psilocybin and MDMA have "no established therapeutic value" is factually inaccurate, unscientific, cruel and causing unnecessary suffering and suicide by denying Australians life saving treatments.
If you feel as strongly about this as I do, please go here to learn how you can voice your support.
It is free to do, doesn't take very long, and if you do it, we can maximise the chance that this change will happen, improve the quality of life for a large number of Australians and achieve our collective mission of shifting the paradigm in mental health so that more people have the chance to get well.
The public submissions period is only open until COB May 27. So please take action now before you miss your chance to take part.
Thank you in advance, we’ll all be celebrating soon when we make history together.
Template for Patients
Subject 1: Please help to make innovative treatment available
Subject 2: Please help to reschedule MDMA & psilocybin
To my patients,
I’m writing this email to ask for your assistance.
As you may know, I’ve been deeply interested in the fast developing field of psychedelic research in recent times. I am extremely optimistic and excited about how psychedelic-assisted therapy may be able to help those suffering from mental illness to achieve much better outcomes and return to better standards of living.
Currently, there are applications that have been submitted to the TGA to reschedule MDMA and psilocybin for use in a therapeutic setting for treatment resistant patients.
Rescheduling these substances will allow some patients the opportunity to begin receiving these treatments outside of a research setting. It is an important step in making them available to the wider community.
I have just made a submission in the TGA’s public submissions process in support of these applications. I would like to ask you to do the same.
The TGA puts extra weight on submissions from healthcare providers, researchers and consumers/patients in the healthcare system. As such, this is an opportunity for your voice to be heard in which treatments you are able to access as a part of your care.
Mind Medicine Australia - the not-for profit organisation that wrote the application - has put together a how-to guide for making a submission. Please take a look at the guide and make a submission to support these applications so you - as a patient in the healthcare system - can have more options regarding your treatment.
Thank you for taking the time to support this